20225 ⎘
Medicinal preparations containing organic active ingredients; Amines having sulfur, e.g. thiurams (>N—C(S)—S—C(S)—N< and >N—C(S)—S—S—C(S)—N<), Sulfinylamines (—N=SO), Sulfonylamines (—N=SO)
AGENT FOR CONTROLLING CELLS CONSTITUTING CANCER MICROENVIRONMENT OR INFLAMMATORY MICROENVIRONMENT
#302ADMINISTRATION OF SERINE PROTEASE INHIBITORS TO THE STOMACH
#303Compound and Composition for Use in the Preventive and/or Curative Treatment of Diseases of the Central Nervous System Characterised by a Decline in Neuronal Plasticity, in Particular Characterised by a Decline in Synaptic Plasticity
#304ORGANIC COMPOUNDS
#305TOPICAL DERMATOLOGIC ACNE TREATMENT CREAM COMPOSITION AND METHOD OF MANUFACTURE
#306Composition and method for preventing or treating hangover symptoms
#307ANALOGUES OF CYSTEAMINE AS THERAPEUTIC AGENTS FOR CYSTIC FIBROSIS
#308Methods for Cancer Therapy
#309METHODS AND COMPOSITIONS FOR REGULATING GLUCOSE HOMEOSTASIS
#310METHODS OF TREATING LIVER DISEASES ASSOCIATED WITH PORTAL TRACT OR PERIPORTAL INFLAMMATION
#311COMPOSITION FOR TREATING AND PREVENTING MALE SEXUAL DISORDERS
#312Use of cysteamine and derivatives thereof to suppress tumor metastases
#313Medium chain fatty acids for use in the prevention or treatment of cardiac enlargement and/or valvular heart disease
#314Use of Mustard Seed Oil (Allyl Isothiocyanate) to relieve headache pain
#315Inhibitors of SARM1 NADase activity and uses thereof
#316Methods of treating or preventing preterm labor
#317Antiviral supplement formulations
#318Calmodulin inhibitors for the treatment of ribosomal disorders and ribosomapathies
#319Formulations of cysteamine and cystamine
#320Compounds and methods for inhibiting CYP26 enzymes
#321TREATMENT OF ASTHMA WITH CYSTEAMINE
#322Homotaurine-enriched compositions and methods of use for animal health
#323TARGETING PAX2 FOR THE TREATMENT OF BREAST CANCER
#324DIETARY SUPPLEMENTS CONTAINING PROBIOTICS
#325Inhibiting senescent processes in beta cells for the prevention of type 1 diabetes
#326Use of sesquiterpene derivative
#327ENGINEERED ANTIMICROBIAL AMPHIPHILIC PEPTIDES AND METHODS OF USE
#328Edible Energy Composition
#329Isothiocyanate functional surfactants, formulations incorporating isothiocyanate functional surfactants and associated methods for treating biofilms
#330Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use
#331Combination treatments for opioid crisis
#332Disulfiram and metal salt staggered oral dosing regimen and staggered-release oral unit dosage forms
#333METHODS OF TREATING PRADER WILLI SYNDROME AND CONDITIONS ASSOCIATED WITH LOW BASAL METABOLIC RATE OR HYPERPHAGIA USING A KATP CHANNEL OPENER
#334Compositions and methods for targeting cancers
#335Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid
#336COMBINATION MEDICATION FOR NEURO-DEGENERATIVE DISEASES AND SIDE-EFFECTS ASSOCIATED WITH COGNITION EFFECTING PHARMACEUTICALS
#337Composition for promotng bone formation with fermented oysters and seaweed
#338DBH inhibitors for treating or preventing memory loss
#339Functionalized magnetic nanoparticles and use in imaging amyloid deposits and neurofibrillary tangles
#340Combinations of β-lactam compounds and probenecid and uses thereof
#341Methods of inhibiting serum glucocorticoid induced kinase 1 (SGKI) as a treatment for salt and water balance diseases
#342Compositions, methods of treatment, and containers including compositions
#343Methods for storing Cysteamine formulations and related methods of treatment
#344METHODS OF TREATING ATTENTION DEFICIT HYPERACTIVITY DISORDER
#345METHODS FOR CANCER THERAPY
#346Methods and nutraceutical compositions for the prevention and/or mitigation of veisalgia
#347Use of isothiocyanate functional surfactants as Nrf2 inducers to treat epidermolysis bullosa simplex and related diseases
#348SYNERGISTIC COMPOSITION FOR INHIBITING ADVANCED GLYCATION END PRODUCT CROSSLINKING
#349NOVEL COMBINATION AND USE
#350Mineral salt-sulfonic acid compositions and methods of use
#351Method to screen compounds for antifungal activity and pharmaceutical compositions and methods to treat fungal diseases by inhibiting spore germination
#352Metal delivery agents and therapeutic uses of the same
#353PROMOTION OF T LYMPHOCYTE PROLIFERATION
#354Delayed release cysteamine bead formulation, and methods of making and using same
#355Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use
#356NOVEL USE OF SESQUITERPENE DERIVATIVE
#357Isothiocyanate functional surfactant and associated method of use
#358Edible energy composition
#359PENCILLAMINE ORAL COMPOSITION
#360Compound of glycosaminoglycan and its fabrication method as well as application
#361Cancer therapy
#362Composition and method for enhancing wound healing
#363PHARMACEUTICAL COMPOSITIONS AND METHODS UTILIZING A D-AMINO ACID
#364Bicyclic compounds
#365METHODS AND COMPOUNDS FOR TREATING ALCOHOL USE DISORDERS AND ASSOCIATED DISEASES
#366Compositions and methods for treatment of diabetic neuropathies
#367Combination treatments for opioid crisis
#368Formulations of cysteamine and cysteamine derivatives
#369Process of purifying methionine
#370NOOTROPIC AND SKIN SUPPLEMENT COMPOSITIONS AND METHOD TO PROVIDE A TAILORED SUPPLEMENT
#371MEDICAL AND NUTRITIONAL COMPOSITIONS AND METHODS OF USE
#372METHODS AND COMPOSITIONS RELATING TO THE TREATMENT OF BENIGN SKIN TUMORS
#373Compositions for treating amyotrophic lateral sclerosis
#374Administration of serine protease inhibitors to the stomach
#375INHIBITION OF BIOFILM ORGANISMS
#376ORGANIC COMPOUNDS
#377Microparticles comprising a sulphur-containing compound
#378USE OF CYSTEAMINE AND DERIVATIVES THEREOF TO SUPPRESS TUMOR METASTASES
#379Nutrition blend for health benefits in animals
#380Nutrition blend for health benefits in animals
#381METHODS FOR THE TREATMENT OF INFECTION
#382METHODS FOR CANCER THERAPY
#383Method for treating pleuroperitoneal membrane cancers by locally injecting disulfiram preparation
#384Use of isothiocyanate functional surfactants as Nrf2 inducers to treat epidermolysis bullosa simplex and related diseases
#385Methods for storing cysteamine formulations and related methods of treatment
#386SHELLAC MICROCAPSULE FORMULATIONS AND COMPOSITIONS
#387FORMULATION FOR ENHANCED TRANSDERMAL ABSORPTION OF DRUG
#388METHODS FOR IMPROVED DELIVERY OF AMINOTHIOLS, DIMERS OF AMINOTHIOLS, AND HETERODIMERS COMPOSED OF AMINOTHIOLS
#389Prolonged release pharmaceutical composition comprising cysteamine or salt thereof
#390Compositions for controlled release of cysteamine and systemic treatment of cysteamine sensitive disorders
#391Enterically coated cysteamine, cystamine and derivatives thereof
#392Methods for the biosynthesis of taurine or hypotaurine in cells
#393ACAT1 inhibitors for treating cancer
#394Use of Thiol Compounds to Treat Neurological Disease
#395DIETARY SUPPLEMENTS AND FORMULATIONS
#396DIETARY SUPPLEMENTS AND FORMULATIONS
#397COMBINATION MEDICATION FOR NEURO-DEGENERATIVE DISEASES AND SIDE-EFFECTS ASSOCIATED WITH COGNITION EFFECTING PHARMACEUTICALS
#398Methods for improved protection and delivery of aminothiols and analogs thereof
#399DBH inhibitors for treating memory loss
#400Antibacterial S-heterosubstituted disulfides
#401Compositions for treating amyotrophic lateral sclerosis
#402USE OF N-ACETYLCYSTEINE TO TREAT CNS DISORDERS
#403Cysteamine as Neutrophil Elastase Inhibitor
#404Methods of treating non-alcoholic steatohepatitis (NASH) using cysteamine compounds
#405Modulators of Sestrin-GATOR2 interaction and uses thereof
#406DRUGS WITH IMPROVED HYDROPHOBICITY FOR INCORPORATION IN MEDICAL DEVICES
#407Disulfiram formulation
#408Compositions and methods for the treatment of diseases involving mucin
#409METHODS AND COMPOSITIONS FOR TREATING DISEASES
#410Compositions and methods for treatment of prediabetes
#411Hair-growth promoting composition and usage thereof
#412Combination comprising an aminothiolester compound or a pharmaceutically acceptable salt thereof and a compound able to increase the H2O2 level in cancer cells of a subject
#413Isothiocyanate functional surfactant and associated method of use
#414Edible energy composition
#415METHODS AND COMPOSITIONS FOR TREATMENT OF METASTATIC AND REFRACTORY CANCERS AND TUMORS
#416SUPPLEMENTAL HEALTH BEVERAGE AND METHOD
#417Topical dapsone and dapsone/adaplene compositions and methods for use thereof
#418Antiviral supplement formulations
#419Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use
#420Compositions and methods for treating cardiovascular related disorders
#421Topical dapsone and dapsone/adapalene compositions and methods for use thereof
#422AEROSOLIZED DAPSONE AS A THERAPY FOR INFLAMMATION OF THE AIRWAY AND ABNORMAL MUCOCILIARY TRANSPORT
#423Methods and compositions for protection of cells and tissues from computed tomography radiation
#424Process for preparation of cysteamine bitartrate
#425An Amino Thiol for Use in the Treatment of an Infection Caused by the Bacterium Mycobacterium Spp
#426COMBINATION MEDICATION FOR NEURO-DEGENERATIVE DISEASES
#427Drug Combinations For the Treatment of HIV
#428Isothiocyanate functional surfactants, formulations incorporating isothiocyanate functional surfactants and associated methods for treating biofilms
#429Dosage Regimen of Diaryl Sulfide Derivatives
#430Treatment of graft versus host disease in transplant patients
#431Metal delivery agents and therapeutic uses of the same
#432ANTIFUNGAL COMPOSITION/TREATMENT
#433Calmodulin inhibitors for the treatment of ribosomal disorders and ribosomapathies
#434Disulfiram and metal salt staggered oral dosing regimen and staggered-release oral unit dosage forms
#435Labeled inhibitors of prostate specific membrane antigen (PSMA) biological evaluation, and use of imaging agents
#436AMINO ALCOHOL DERIVATIVES FOR THE TREATMENT OF DEMYELINATING PERIPHERAL NEUROPATHIES
#437Methods and compositions for treating cutaneous fungal infections
#438Compositions and methods for treating ocular diseases
#439USE OF CYSTEAMINE AND DERIVATIVES THEREOF TO SUPPRESS TUMOR METASTASES
#440Isothiocyanate functional surfactants, formulations incorporating isothiocyanate functional surfactants and associated methods for treating biofilms
#441METHODS FOR THE BIOSYNTHESIS OF TAURINE OR HYPOTAURINE IN CELLS
#442USE OF ISOTHIOCYANATE FUNCTIONAL SURFACTANTS AS NRF2 INDUCERS TO TREAT EPIDERMOLYSIS BULLOSA SIMPLEX AND RELATED DISEASES
#443METHOD FOR MANUFACTURING NOVEL NITROGEN-CONTAINING COMPOUND OR SALT THEREOF AND MANUFACTURING INTERMEDIATE OF NOVEL NITROGEN-CONTAINING COMPOUND OR SALT THEREOF
#444Pharmaceutical composition for preventing or treating diabetic complications and screening method for preventive or therapeutic agent for diabetic complications
#445Agent for controlling cells constituting cancer microenvironment or inflammatory microenvironment
#446Compositions and methods of modulating s-nitrosylation
#447TOPICAL DAPSONE AND DAPSONE/ADAPALENE COMPOSITIONS AND METHODS FOR USE THEREOF
#448Combination and use
#449FORMULATION
#450Methods of treating Prader-Willi syndrome
#451Microparticles
#452Treatment of Drug-Resistant Microbial Infections
#453MODIFIED TAURINE, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING METABOLIC DISEASES CONTAINING SAME
#454Method for treatment of metastatic and refractory cancers and tumors with an inducer that overcomes inhibition of T cell proliferation
#455Methods and compositions comprising desmopressin in combination with an alpha-adrenergic receptor antagonist
#456Enterically coated cysteamine, cystamine and derivatives thereof
#457Enterically coated cysteamine, cystamine and derivatives thereof
#458Enterically coated cysteamine, cystamine and derivatives thereof
#459DELAYED RELEASE CYSTEAMINE BEAD FORMULATION, AND METHODS OF MAKING AND USING SAME
#460DELAYED RELEASE CYSTEAMINE BEAD FORMULATION, AND METHODS OF MAKING AND USING SAME
#461DELAYED RELEASE CYSTEAMINE BEAD FORMULATION, AND METHODS OF MAKING AND USING SAME
#462Compositions and Methods for Treatment of Prediabetes
#463HIF-2α inhibitors for treating iron overload disorders
#464Methods of treating non-alcoholic steatohepatitis (NASH) using cysteamine products
#465BISPHENOL DERIVATIVES AND THEIR USE AS ANDROGEN RECEPTOR ACTIVITY MODULATORS
#466Organic Compounds
#467DEGRADABLE NETWORKS FOR SUSTAINED RELEASE AND CONTROLLED RELEASE DEPOT DRUG DELIVERY APPLICATIONS
#468METHODS OF TREATMENT OF ACNE VULGARIS USING TOPICAL DAPSONE COMPOSITIONS
#469Acetaminophen-Containing Analgesic Formulations With Reduced Hepatotoxicity
#470Multi-ingredient pharmaceutical composition for use in cancer therapy
#471Administration of serine protease inhibitors to the stomach
#472LYSINE DEMETHYLASE INHIBITORS FOR MYELOPROLIFERATIVE OR LYMPHOPROLIFERATIVE DISEASES OR DISORDERS
#473DRUGS WITH IMPROVED HYDROPHOBICITY FOR INCORPORATION IN MEDICAL DEVICES
#474DIETARY SUPPLEMENTS CONTAINING PROBIOTICS
#475Method for the induction of phase 2 related genes in a mammal comprising administering exemestane
#476Emulsion of Carotenoids and Ocular Antioxidants
#477Cysteamine in the treatment of fibrotic disease
#478Nutritional composition for improving muscle function and daily activity
#479Pharmaceutical compositions and methods utilizing a D-amino acid
#480Compounds and methods for inhibiting production of trimethylamine
#481Compound of glycosaminoglycan and its fabrication method as well as application
#482Methods for inhibiting conversion of carnitine to trimethylamine (TMA)
#483Methods for storing cysteamine formulations and related methods of treatment
#484Compositions comprising eicosapentaenoic acid and a hydroxyl compound and methods of use thereof
#485METHODS OF TREATMENT OF ACNE VULGARIS USING TOPICAL DAPSONE COMPOSITIONS
#486Dosage Regimen of Diaryl Sulfide Derivatives
#487Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid
#488METHODS FOR ASSESSING RESPONSIVENESS TO ASTHMA TREATMENT BASED ON VNN-1 EXPRESSION AND PROMOTER METHYLATION
#489Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use
#490DAPSONE TO TREAT ROSACEA
#491LXR agonists and uses thereof
#492METHODS OF TREATING OR PREVENTING PRETERM LABOR
#493Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use
#494Pharmaceutical composition
#495SYNTHESIS AND GROWTH REGULATORY ACTIVITY OF A PROTOTYPE MEMBER OF A NEW FAMILY OF AMINOTHIOL RADIOPROTECTORS
#496Antibacterial S-heterosubstituted disulfides
#497BENIGN PROSTATIC HYPERPLASIA ADD-ON THERAPY
#498Edible energy composition
#499Enterically coated cysteamine, cystamine and derivatives thereof
#500Treatment of fibrosis
#501Isothiocyanate functional surfactant formulation and associated method of use
#502Isothiocyanate functional surfactant and associated method of use
#503Methods of protecting an organ using tetrahydrocurcumin and phosphatidylcholine
#504Methods for Improved Delivery of Aminothiols, Dimers of Aminothiols, and Heterodimers Composed of Aminothiols
#505NUTRITIONAL COMPOSITIONS
#506Method for treatment of metastatic and refractory cancers and tumors with an inducer that overcomes inhibition of T cell proliferation
#507Use of disulfiram for inflammatory breast cancer therapy
#508METHODS OF REACTIVATING A LATENT HUMAN IMMUNODEFICIENCY VIRUS
#509Composition and method for enhancing wound healing
#510ADO-resistant cysteamine analogs and uses thereof
#511Dietary supplements and formulations
#512Antimicrobial compositions comprising glyceryl nitrates
#513ORGANIC THIOPHOSPHATE ANTIRETROVIRAL AGENTS
#514Therapy regimen and methods to sensitize cancer cells treated with epigenetic therapy to PARP inhibitors in lung cancer
#515Therapy regimen and methods to sensitize cancer cells treated with epigenetic therapy to PARP inhibitors in ovarian cancer
#516Combination Medication for Neuro-Degenerative Diseases
#517Therapy regimen and methods to sensitize cancer cells treated with epigenetic therapy to PARP inhibitors in multiple cancers
#518Methods of treating Prader-Willi Syndrome
#519Disulfiram Compositions and Treatments for Brain Tumors
#520Enterically coated cysteamine, cystamine and derivatives thereof
#521Delayed Release Cysteamine Bead Formulation, and Methods of Making and Using Same
#522Enterically coated cysteamine, cystamine and derivatives thereof
#523METHODS OF TREATING PRADER-WILLI SYNDROME
#524Methods and compositions for treating diseases
#525Castration-resistant prostate cancer
#526TREATMENT OF GASTROINTESTINAL AND OTHER DISORDERS
#527Dietary supplement containing alkaline electrolyte buffers
#528COMPOSITIONS AND METHODS FOR PREVENTION AND TREATMENT OF METABOLIC STEATOSIS AND STEATOHEPATITIS
#529TOPICAL DAPSONE AND DAPSONE/ADAPLENE COMPOSITIONS AND METHODS FOR USE THEREOF
#530SYNTHESIS AND GROWTH REGULATORY ACTIVITY OF A PROTOTYPE MEMBER OF A NEW FAMILY OF AMINOTHIOL RADIOPROTECTORS
#531KCNQ channels as therapeutic targets
#532Inhibition of Biofilm Organisms
#533Dithiol mucolytic agents
#534Method and kit for administering γ-glutamyl-D-cysteine for the prevention of reperfusion injury following ischemic stroke
#535ANTICONVULSIVE PHARMACEUTICAL COMPOSITIONS
#536Functionalized magnetic nanoparticles and use in imaging amyloid deposits and neurofibrillary tangles
#537Use of Cysteamine and Derivatives Thereof to Suppress Tumor Metastases
#538Polymeric prodrug of disulfiram and application thereof
#539COMBINATION THERAPY FOR THE TREATMENT OF CANCER
#540Method for treating inflammation and pain
#541Delayed Release Cysteamine Bead Formulation, And Methods Of Making And Using Same
#542Antimicrobial compositions with cysteamine
#543Methods for the biosynthesis of taurine or hypotaurine in cells
#544Enterically coated cysteamine, cystamine and derivatives thereof
#545Methods of treating non-alcoholic steatohepatitis (NASH) using cysteamine products
#546Compositions for treating amyotrophic lateral sclerosis
#547Methods of Treating Huntington's Disease Using Cysteamine Compositions
#548Pharmaceutical composition for treating disease associated with demyelination of neurons and method of using the pharmaceutical composition
#549Medicinal composition for inhibiting formation and/or enlargement of cerebral aneurysm or shrinking same
#550USE
#551Use of Cysteamine in Treating Infections caused by Yeasts/Moulds
#552DELAYED RELEASE CYSTEAMINE BEAD FORMULATION, AND METHODS OF MAKING AND USING SAME
#553Energetic Beer, Flavored Beer or Energetic Drink Based on Beer
#554LIQUID CONCENTRATED FORMULA
#555Pharmaceutical composition for treating a microbial infection
#556Bicyclic compounds
#557USE OF PETROSELINIC ACID TO FIGHT AGAINST AESTHETIC DISORDERS OF THE BODY FIGURE
#558Methods of treating pulmonary sarcoidosis
#559Methods of making a deuterated or a non-deuterated molecule and pharmaceutical formulations for treatment
#560COMPARATIVE EFFICACY AND TOLERABILITY OF DAPSONE 5% IN ADULT VERSUS ADOLESCENT FEMALES WITH ACNE VULGARIS
#561Topical dapsone and dapsone/adapalene compositions and methods for use thereof
#562Isothiocyanate functional surfactant and associated method of use
#563Isothiocyanate functional surfactant and associated method of use
#564Lysine derivative having an isothiocyanate functional group and associated method of use
#565TREATMENT OF GRAFT VERSUS HOST DISEASE IN TRANSPLANT PATIENTS
#566Combined therapy for cystic fibrosis
#567Topical oral composition for alleviating dry mouth symptoms and for treating mouth ulcers
#568Enterically coated cysteamine, cystamine and derivatives thereof
#569Enterically coated cysteamine, cystamine and derivatives thereof
#570Crystalline phase of (3S.3S′) 4,4′-disulfanediylbis(3-aminobutane 1-sulfonic acid) with L-lysine
#571ENTERICALLY COATED CYSTEAMINE, CYSTAMINE AND DERIVATIVES THEREOF
#572Antiviral supplement formulations
#573Calmodulin inhibitors for the treatment of ribosomal disorders and ribosomapathies
#574Treatment of MeCP-2 Associated Disorders
#575Methods and compositions for transdermal delivery
#576Methods and compositions for transdermal delivery
#577COMPOSITIONS AND METHODS FOR TREATMENT OF CHRONIC FATIGUE
#578Labeled inhibitors of prostate specific membrane antigen (PSMA) biological evaluation, and use of imaging agents
#579Treatment for vitiligo
#580Treatment for neurodegeneration
#581Styrenyl derivative compounds for treating ophthalmic diseases and disorders
#582METHODS AND COMPOSITIONS FOR COUNTERMEASURES AGAINST RADIATION
#583METHODS OF REACTIVATING A LATENT HUMAN IMMUNODEFICIENCY VIRUS
#584COMBINATION TREATMENT FOR ALCOHOL DEPENDENT PATIENTS
#585Regulators of aldehyde dehydrogenase ALDH3A1 and related therapeutic methods
#586Antimicrobial compositions comprising glyceryl nitrates
#587Prion protein ligands as therapeutic agents for neurodegenerative disorders
#588MINERAL SALT-SULFONIC ACID COMPOSITIONS AND METHODS OF USE
#589Composition including dapsone for preventing or treating side effect of steroid in subject and use of the composition
#590Styrenyl derivative compounds for treating ophthalmic diseases and disorders
#591Styrenyl derivative compounds for treating ophthalmic diseases and disorders
#592Isothiocyanate functional compound and associated method of use
#593Compositions and methods for the treatment of asthma and allergy
#594Use of Cysteamine and Derivatives Thereof to Treat Mitochondrial Diseases
#595Metal delivery agents and therapeutic uses of the same
#596Compounds for treating inflammation and pain
#5976,7-Dihydro-5H-benzo[7]annulene derivatives, processes for their preparation, pharmaceutical products comprising them and their use for preparing medicaments
#598Compound of glycosaminoglycan and its fabrication method as well as application
#599Dithiol mucolytic agents
#600DOSAGE FORM COMPRISING A STEROID 5-ALPHA-REDUCTASE INHIBITOR AND AN ALPHA BLOCKER, PROCESS FOR PREPARING OF A DOSAGE FORM, USE OF DOSAGE FORM, METHOD FOR THE TREATMENT OR PROPHYLAXIS OF A DISEASE OR CONDITION MEDIATED BY ANDROGEN